-
InDex Pharmaceuticals provides an update on company’s future
February 26, 2024 Non Regulatory
-
InDex Pharmaceuticals discontinues the development of cobitolimod
February 26, 2024 Regulatory
InDex Pharmaceuticals published the Year-end Report for 2023 on February 21, 2024.
-
Annual Report 2023
-
Interim Report Q1 2024
-
Annual General Meeting 2024